Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.59 |
| ▸ | STAT1 | P42224 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265476 | 0.98 | STAT3 (0.57) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL14054511 | 0.98 | STAT3 (0.57) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL7762016 | 0.91 | STAT3 (0.54) | STAT3STAT1MAPTKDM4ENPC1 | |
| SCHEMBL5013670 | 0.91 | STAT3 (0.54) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL899162 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL5067206 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL31435711 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL31499126 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL31435710 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD | |
| SCHEMBL28780957 | 0.89 | STAT3 (0.52) | STAT3STAT1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119454945-A | Ultrasonic activated carrier-free nano-drug and preparation method and application thereof | 浙江大学 | 2025-02-18 | — | — | CN | claimed |
| CN-107219280-A | A kind of Metalloporphyrins gas sensor element and its preparation method and application | 济南大学 | 2017-09-29 | — | — | CN | claimed |
| CN-105288646-A | Photosensitizer phospholipid compound as well as pharmaceutical composition and application of photosensitizer phospholipid compound | UNIV SOUTHEAST | 2016-02-03 | — | — | CN | claimed |
| US-6825343-B2 | REFLUXING TETRACYANOETHYLENE OXIDE WITH TETRAPHENYLPORPHYRIN TO FORM (5,10,15,20-TETRAPHENYL-2,3-(3'-DICYANO)CYCLOPROPANO -2,3-CHLORIN); MACROMOLECULE INTERMEDIATES USED AS CHELATE COMPOUNDS; PHOTOSENSITIVITY | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-11-30 | — | — | US | claimed |
| US-20040019201-A1 | 1,3-Dipolar cycloadditions to polypyrrolic macrocycles | MACALPINE JILL KIRSTEN (US) | 2004-01-29 | — | — | US | claimed |
| US-6620929-B1 | Condensing tetracyanoethylene oxide with porphyrins to form macromolecules such as 5,10,15,20-tetraphenyl-2,3-(3'-dicyano) cyclopropano-2,3-chlorin, used for photodynamic therapy; cyclization | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2003-09-16 | — | — | US | claimed |
| CN-119219645-B | Preparation method of substituted diphenyl porphyrin-2-formaldehyde | 湖南科技大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-119899348-B | Preparation method of novel photoelectric catalyst of covalent organic framework and photoelectric catalyst thereof | 广东药科大学 | 2025-09-30 | — | — | CN | disclosed |
| WO-2025089384-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089409-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, MOBILE BODY, AND BUILDING MATERIAL | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089411-A1 | COMPOSITION, PREPARATION METHOD FOR COMPOSITION, AND PHOTOELECTRIC CONVERSION ELEMENT | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| CN-119899348-A | Preparation method of novel photoelectric catalyst of covalent organic framework and photoelectric catalyst thereof | 广东药科大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-119899348-A | Preparation method of novel photoelectric catalyst of covalent organic framework and photoelectric catalyst thereof | 广东药科大学 | 2025-04-29 | — | — | CN | disclosed |
| US-5990363-A | Method for oxidizing alkanes using novel porphyrins synthesized from dipyrromethanes and aldehydes | SUN COMPANY, INC. (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1999020081-A2 | HIGHLY TRANSPARENT NON-METALLIC CATHODES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1999-04-22 | — | — | WO | disclosed |
| US-5760217-A | Porphyrins and their synthesis from dipyrromethanes and aldehydes | SUN COMPANY, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| US-5723677-A | Method for hydroperoxide decomposition using novel porphyrins synthesized from dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1998-03-03 | — | — | US | disclosed |
| US-5571908-A | Porphyrins | SUN COMPANY, INC. (R&M) (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0665056-A2 | Method for oxidizing alkanes using halocarbyl-substituted porphyrins synthesized from meso-halocarbyl-dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1995-08-02 | — | — | EP | disclosed |
| EP-0665230-A2 | Halocarbyl-substituted porphyrins and their synthesis from meso-halocarbyl-dipyrromethanes and aldehydes | SUN COMPANY, INC. (R&M) (US) | 1995-08-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019201-A1 | 1,3-Dipolar cycloadditions to polypyrrolic macrocycles | DHPS, DDT, ADCYAP1R1 | STAT3 4802/4885STAT1 4772/4885ALDH1A1 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.